Biotechnology

MorphoSys signs anti-bacterial deal with Absynth – 2-Sep-2010

Secures access to innovative targets associated with Staphylococcus aureus infections

IntelGenx and RedHill sign anti-migraine film product deal – 31-Aug-2010

RedHill will pay IntelGenx US$2.1m for rights to oral thin film product

Lonza enters viral vaccine market – 31-Aug-2010

Acquires Vivante, a manufacturer of GMP viral-based therapeutics

Genzyme rejects Sanofi-aventis bid – 31-Aug-2010

Says the proposal is opportunistic and does not recognise potential of product pipeline

CMC Biologics completes first stage of expansion – 25-Aug-2010

Adds single-use facility to Seattle plant

Making the French connection – 2-Sep-2010

The annual CPhI events move back to Paris next month. Hilary Ayshford questioned the organisers on their expectations for the shows and the future outlook

A silent revolution – 5-May-2010

Increased understanding of RNA interference has led to an explosion of gene silencing drug research projects. Dr Sarah Houlton reviews the progress being made in recent drug trials and looks at the remaining challenges

Meeting biopharma needs – 7-Apr-2010

While the recession is increasing demand for contract services, the growth of biopharmaceutical development is creating new needs. Maria Lundberg from Recipharm explains how services providers are responding

Fast track to tag-free proteins – 11-Sep-2009

Protein fusion technology using affinity tags has greatly simplified the process of purifying recombinant proteins. Now a single-step technology from Bio-Rad addresses the bottleneck in the subsequent tag removal process

A growing throw-away culture – 7-Apr-2009

Eric S Langer, president and managing partner of biotech marketing research company BioPlan Associates, highlights changes in attitudes to disposables use in biopharmaceutical manufacturing